Literature DB >> 30021147

Viral Infection "Interferes" with Glucose Tolerance.

Kaitlin Kiernan1, Nancie J MacIver2.   

Abstract

In this issue of Immunity, Šestan et al. (2018) show that viral-induced inflammation leads to insulin resistance in skeletal muscle, followed by compensatory hyperinsulinemia, which promotes the anti-viral effector response of CD8+ T cells. Interestingly, this leads to persistent glucose intolerance and the progression of type 2 diabetes in pre-diabetic animals.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30021147     DOI: 10.1016/j.immuni.2018.06.013

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  4 in total

1.  Lupenone is a good anti-inflammatory compound based on the network pharmacology.

Authors:  Feng Xu; Liubo Yang; Xulong Huang; Yuqing Liang; Xiangpei Wang; Hongmei Wu
Journal:  Mol Divers       Date:  2019-02-22       Impact factor: 2.943

2.  Risk factors predicting hospital length of stay in older patients with type 2 diabetes with Covid-19.

Authors:  Bilal Katipoglu; Mehmet Ilkin Naharci; Eray Serdar Yurdakul
Journal:  J Diabetes Metab Disord       Date:  2022-07-07

Review 3.  Inflammation and vascular dysfunction: The negative synergistic combination of diabetes and COVID-19.

Authors:  Andrea Mario Bolla; Cristian Loretelli; Laura Montefusco; Giovanna Finzi; Reza Abdi; Moufida Ben Nasr; Maria Elena Lunati; Ida Pastore; Joseph V Bonventre; Manuela Nebuloni; Stefano Rusconi; Pierachille Santus; Gianvincenzo Zuccotti; Massimo Galli; Francesca D'Addio; Paolo Fiorina
Journal:  Diabetes Metab Res Rev       Date:  2022-07-22       Impact factor: 8.128

4.  Understanding factors influencing the length of hospital stay among non-severe COVID-19 patients: A retrospective cohort study in a Fangcang shelter hospital.

Authors:  Shishi Wu; Lanping Xue; Helena Legido-Quigley; Mishal Khan; Hua Wu; Xiaoxiang Peng; Xuewen Li; Ping Li
Journal:  PLoS One       Date:  2020-10-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.